We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Basecamp Research Stock

Invest in or calculate the value of your shares in Basecamp Research or other pre-IPO companies through EquityZen's platform.

Get Started

Basecamp Research Stock

Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products

About Basecamp Research Stock

Founded

2019

Industries

Software, Artificial Intelligence, Data and Analytics

Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. We match and refine novel proteins for our partners' exact industrial, therapeutic or diagnostic applications using BaseGraph™, a new generation of AI design that is powered by the first-ever high-resolution map of global genetic biodiversity. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're a team of explorers, scientists and policy experts driven by our ambition to protect and learn from nature's diversity, whilst delivering life-changing breakthroughs to those who need them most.

Basecamp Research Press Mentions

Stay in the know about the latest news on Basecamp Research

Basecamp Research Management

Leadership team at Basecamp Research

Co-Founder

Glen Gowers

Co-Founder

Oliver Vince

Locked Features

Join now and verify your accreditation status to gain access to:

  • Basecamp Research current valuation
  • Basecamp Research stock price
  • Available deals in Basecamp Research and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Basecamp Research Stock

How to invest in Basecamp Research stock?

Accredited investors can buy pre-IPO stock in companies like Basecamp Research through EquityZen funds. These investments are made available by existing Basecamp Research shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Basecamp Research stock?

Shareholders can sell their Basecamp Research stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."